As Tsg101, Vps25, and Chmp2a have been described to have additional cellular functions, including autophagy functions [45–48], it suggests that oAβ treatment and PrPC levels may influence not just exosome biogenesis but also other critical cellular pathways implicated in AD. The gene discussed is CHMP2A; the disease is Alzheimer disease.